NCT04202926 is a NA clinical trial of real coil in Methamphetamine-dependence, sponsored by Shanghai Mental Health Center.

Who is sponsoring NCT04202926?

NCT04202926 is sponsored by Shanghai Mental Health Center.

What drugs are being tested in NCT04202926?

Interventions in NCT04202926: real coil, sham coil.

What condition does NCT04202926 study?

NCT04202926 studies Methamphetamine-dependence.

Is NCT04202926 still recruiting?

NCT04202926 is currently completed. Last updated 22 November 2023.

Last reviewed 2023-11-22 · How we verify

NCT04202926

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Repetitive dTMS Intervention for Methamphetamine Addiction

Completed NA Last updated 22 November 2023

What this trial tests

NA trial testing real coil in Methamphetamine-dependence in 23 participants. Completed in 30 October 2023.

Timeline

30 December 2019

Primary endpoint
30 May 2023

30 October 2023

Quick facts

Lead sponsor	Shanghai Mental Health Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	23
Start date	30 December 2019
Primary completion	30 May 2023
Estimated completion	30 October 2023
Sites	1 location across China

Drugs / interventions tested

real coil
sham coil

Conditions studied

Methamphetamine-dependence — all drugs for Methamphetamine-dependence →

Sponsor

Shanghai Mental Health Center — full company profile →

Who can join

Adults 18 to 60, any sex, with Methamphetamine-dependence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A growing body of evidence suggests a wide range of brain areas including medial prefrontal cortex (mPFC), dorsolateral prefrontal cortex (DLPFC) and other subcortical regions, such as anterior cingulate cortex (ACC) are critical for regulating cognitive control over decisions and involving in drug related cue processing. Previous studies have demonstrated that transcranial magnetic stimulation (rTMS) over dorsolateral prefrontal cortex reduces craving for meth dependences. Specifically, the H7 coil induces a magnetic field can target mPFC and ACC. In this study, the investigators investigated whether repeated dTMS intervention of medial prefrontal and cingulate cortices in methamphetamine addiction could reduce the subjective craving and improve the cognitive abilities.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Deep magnetic stimulation targeting the medial prefrontal and anterior cingulate cortices for methamphetamine use disorder: a randomised, double-blind, sham-controlled study.
Zhao D, Zeng N, Zhang HB, Zhang Y, et al · · 2023 · cited 6× · PMID 37781340 · DOI 10.1136/gpsych-2023-101149

Verify or expand the search:

Other recruiting trials for Methamphetamine-dependence

Currently open trials in the same condition.

NCT06701487 — Role of Pavlovian Mechanisms for Control Over Substance Use · recruiting
NCT06233799 — Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder · Phase 3 · recruiting
NCT06027814 — MHealth Incentivized Adherence Plus Patient Navigation · NA · active not recruiting
NCT06434818 — Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders · Phase 2 · recruiting
NCT05162391 — Inflammation in Methamphetamine and STIs (IMSTI) · NA · active not recruiting

Other Shanghai Mental Health Center trials

Trials by the same sponsor.

NCT07480408 — Neural Mechanisms of the Sensorymotor Circuit in Sensory Phenomena in OCD · NA · not yet recruiting
NCT07479771 — tTIS Targeted of the Striatum as an Intervention for MUD Patients · NA · not yet recruiting
NCT07472673 — Transcranial Temporal Interference Stimulation Targeted of the Amygdala as an Intervention for Alcohol Use Disorder Pati · NA · not yet recruiting
NCT07484750 — Efficacy and Influencing Factors of Mindfulness-Based Exposure Group Therapy for OCD · NA · recruiting
NCT07311655 — Validation of the Accuracy of an AI-Based System for Diagnosing Anxiety Disorders · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04202926 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shanghai Mental Health Center
Last refreshed: 22 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04202926.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing